Hims & Hers Health shareholders have until Nov 2 to file for lead plaintiff status

News provided byHims & Hers Health, Inc · 2 min read
NEW ORLEANS, Sept. 4, 2026 /CourierPR/ -- Hims & Hers Health shareholders have until November 2, 2026, to file for lead plaintiff status in a securities class action lawsuit, according to ClaimsFiler, a free shareholder information service. The deadline is for those who purchased or otherwise acquired the company’s securities between August 4, 2025, and July 29, 2026, inclusive.
The lawsuit, pending in the United States District Court for the Northern District of California, alleges that Hims & Hers Health and certain of its executives failed to disclose material information during the class period, thereby violating federal securities laws. The FTC filed the lawsuit on July 29, 2026, alleging that the telehealth provider shared consumers' sensitive health information with third-party advertising platforms, despite claiming to maintain privacy. The FTC also claimed that the company misled users about its billing and cancellation practices.
According to the FTC, Hims & Hers Health failed to clearly disclose that it charges consumers for prescriptions almost immediately after they submit an intake form, despite informing users that they would have the opportunity to consult with a medical provider to find a treatment that is "right for them." As a result of this news, the price of Hims & Hers Health shares plummeted by $4.32, or 14.73%, to close at $25.00 on July 29, 2026, on unusually heavy trading volume.
Investors who believe they may have been affected by these alleged practices are encouraged to visit ClaimsFiler's website at [www.claimsfiler.com/cases/nyse-hims-1/](www.claimsfiler.com/cases/nyse-hims-1/) or call (833) 538-3604 to get more information and seek legal advice. Lawyers at Kahn Swick & Foti, LLC are available to discuss legal options.
Hims & Hers Health, based in San Francisco, has faced scrutiny over its business practices, particularly regarding consumer privacy and transparency. The case, Velanki v. Hims & Hers Health, Inc., et al., 26-cv-09313, is ongoing.
ClaimsFiler, founded with the mission to help retail investors recover from securities class action settlements, offers free services to investors. Investors can register for free to gain access to information and settlement websites, upload their portfolio transactional data to be notified about relevant securities cases, and submit inquiries for free case evaluations.